Erin M. Coyne

机构：University of Notre Dame, Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore · ORCID：0000-0002-0393-6600

发表论文 73 篇 · 总被引 575 次 · h-index 12

代表论文

• Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial (2026 · Nature Communications · 被引 16)
• Cancer-Associated Fibroblasts Promote Epithelial–Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer (2026 · Cancer Research · 被引 1)
• A Randomized Phase II Study: CRS207/GVAX plus Anti–PD-1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC (2026 · Cancer Immunology Research · 被引 1)
• Supplemental Table 1 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy (2025 · 被引 1)
• Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial (2026 · Nature Communications)
• Abstract 3793: Preventing nk cell activation in the damaged liver induced by cabozantinib/pd-1 blockade increases survival in hepatocellular carcinoma models (2026 · Cancer Research)